VALIANT LABORATORIES
|
VALIANT LABORATORIES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Profit Before Tax | ₹-1.51 Cr | ₹-0.77 Cr | ₹38 Cr |
| Adjustment | ₹4.29 Cr | ₹2.04 Cr | ₹1.56 Cr |
| Changes In working Capital | ₹-3.93 Cr | ₹-0.37 Cr | ₹25 Cr |
| Cash Flow after changes in Working Capital | ₹-1.15 Cr | ₹0.90 Cr | ₹65 Cr |
| Cash Flow from Operating Activities | ₹1.31 Cr | ₹1.89 Cr | ₹56 Cr |
| Cash Flow from Investing Activities | ₹-53 Cr | ₹-144 Cr | ₹-55 Cr |
| Cash Flow from Financing Activities | ₹45 Cr | ₹152 Cr | ₹-0.93 Cr |
| Net Cash Inflow / Outflow | ₹-6.80 Cr | ₹10 Cr | ₹-0.05 Cr |
| Opening Cash & Cash Equivalents | ₹12 Cr | ₹1.26 Cr | ₹1.31 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹4.92 Cr | ₹12 Cr | ₹1.26 Cr |
Compare Cashflow Statement of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹495.8 Cr | 21.2% | 45.5% | -5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | 21.2% |
45.5% |
-5.4% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses